The impact of gender and anchor drugs on TDF renal toxicity
- PMID: 20859083
- DOI: 10.1097/QAI.0b013e3181ef7930
The impact of gender and anchor drugs on TDF renal toxicity
Comment on
-
Randomized comparison of renal effects, efficacy, and safety with once-daily abacavir/lamivudine versus tenofovir/emtricitabine, administered with efavirenz, in antiretroviral-naive, HIV-1-infected adults: 48-week results from the ASSERT study.J Acquir Immune Defic Syndr. 2010 Sep;55(1):49-57. doi: 10.1097/QAI.0b013e3181dd911e. J Acquir Immune Defic Syndr. 2010. PMID: 20431394 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
